Skip to main content
. 2022 Jul 26;13:919223. doi: 10.3389/fendo.2022.919223

Figure 1.

Figure 1

Impact of diabetes and systemic metabolic factors on respiratory infections. (A) Impact of hyperinsulinemia, hyperglycemia and dyslipidemia on Mycobacterium tuberculosis infection. (B) Impact of hyperglycemia on Influenza A virus infection. (C) Impact of hyperglycemia and renin-angiotensin-aldosterone system (RAAS) dysfunction on SARS-CoV2 infection. Created with BioRender.com.